Correlation Between Alx Oncology and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alx Oncology and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alx Oncology Holdings and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Alx Oncology and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and CRISPR Therapeutics.

Diversification Opportunities for Alx Oncology and CRISPR Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Alx Oncology and CRISPR is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Alx Oncology and CRISPR Therapeutics

Given the investment horizon of 90 days Alx Oncology Holdings is expected to under-perform the CRISPR Therapeutics. In addition to that, Alx Oncology is 1.36 times more volatile than CRISPR Therapeutics AG. It trades about -0.02 of its total potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about 0.0 per unit of volatility. If you would invest  9,539  in CRISPR Therapeutics AG on June 30, 2022 and sell it today you would lose (2,845)  from holding CRISPR Therapeutics AG or give up 29.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Alx Oncology Holdings  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Alx Oncology Holdings 
Alx Oncology Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Alx Oncology Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Alx Oncology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Alx Oncology Price Channel

CRISPR Therapeutics 
CRISPR Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, CRISPR Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Price Channel

Alx Oncology and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alx Oncology and CRISPR Therapeutics

The main advantage of trading using opposite Alx Oncology and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Alx Oncology vs. Repligen Cp
Alx Oncology vs. Amerisourcebergen Corp
Alx Oncology vs. Abiomed
Alx Oncology vs. Boston Scientific Corp
The idea behind Alx Oncology Holdings and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Porsche Automobil Hg
CRISPR Therapeutics vs. Hyundai Motor Reg
CRISPR Therapeutics vs. Ford Motor
CRISPR Therapeutics vs. Magna International
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go